(Press-News.org) (MEMPHIS, Tenn. - April 21, 2015) Researchers have identified a protein that offers a new focus for developing targeted therapies to tame the severe inflammation associated with multiple sclerosis (MS), colitis and other autoimmune disorders. St. Jude Children's Research Hospital scientists led the study which appears today in the scientific journal Immunity.
Investigators showed that the protein NLRP12 works in T cells to limit production of chemical messengers or cytokines that fuel inflammation. T cells are specialized white blood cells produced to eliminate specific infectious agents and other threats. Deletion of the Nlrp12 gene led to increased cytokine production in T cells. Specially bred mice that received T cells deficient in the protein NLRP12 developed more severe symptoms of colitis and the chronic skin condition atopic dermatitis.
The results suggest how mutations in the Nlrp12 gene cause disease, which until now was unclear. "We have identified a possible mechanism of how mutations in Nlrp12 lead to atopic dermatitis and possibly other diseases in humans," said corresponding author Thirumala-Devi Kanneganti, Ph.D., a member of the St. Jude Department of Immunology. "Understanding the precise inner-workings of NLRP12 in T cells will help guide efforts to develop therapies to ease symptoms by taming inflammation driven by T cells."
Researchers also found that NLRP12-deficient mice may offer a much needed mouse model for studying the development of balance and movement problems in people with multiple sclerosis (MS).
NLRP12 belongs to a family of proteins best known for working in the innate immune system to help cells sense threats and then launch the inflammatory response to eliminate them. The innate immune system is the body's first line of defense. It works with T cells and other components of the adaptive immune system to safeguard health.
Previous research from Kanneganti's laboratory showed that rather than fueling production of the cytokines that drive inflammation, NLRP12 played a different role in the innate immune response. Researchers showed that in the innate immune system, NLRP12 worked in the NF-?B signaling pathway to restrain inflammation.
The latest study showed that NLRP12 serves the same anti-inflammatory function in T cells. Investigators demonstrated that NLRP12 works through the NF-?B pathway in T cells to regulate production of interleukin 4 (IL-4) and other cytokines.
"This study provides the first evidence that NLRP12 can function in adaptive immune cells to regulate inflammation and impact various autoimmune disorders," Kanneganti said. "That's important because excessive inflammation plays a role in many human diseases, including cancer."
The findings could also advance efforts to understand and treat MS, a chronic inflammatory disorder in which T cells attack and damage the myelin sheath that insulates nerve fibers. The resulting demyelination disrupts nervous system functioning, causing MS symptoms.
Demyelination and inflammation both occur in the current mouse model of MS and result in progressive paralysis beginning in the tail. Surprisingly, the deletion of Nlrp12 in mice led to different symptoms. The mice had less paralysis, but developed problems with balance and movement, just like MS patients. Investigators linked the new symptoms to increased IL-4 production by T cells that lacked NLRP12. When excess IL-4 was eliminated using various methods, the mice again exhibited classical paralysis rather than the other symptoms related to balance and movement.
INFORMATION:
The study's first author is John Lukens, Ph.D., formerly of St. Jude and now of the University of Virginia. The second author is Prajwal Gurung, Ph.D., a St. Jude postdoctoral fellow who contributed significantly to the study. The other authors are Patrick Shaw, Maggie Barr, Scott Brown, Peter Vogel and Hongbo Chi, all of St. Jude; and Md. Hasan Zaki, formerly of St. Jude and now of the University of Texas Southern Medical School, Dallas.
The study was funded in part by grants (AR056296, CA163507, AI101935) from the National Institutes of Health and ALSAC.
St. Jude Media Relations Contacts
Carrie Strehlau
Desk: (901) 595-2295
Cell: (901) 297-9875
carrie.strehlau@stjude.org
Summer Freeman
Desk: (901) 595-3061
Cell: (901) 297-9861
summer.freeman@stjude.org
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude is working to increase the overall survival rate for childhood cancer to 90 percent in the next decade. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food--because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude at @stjuderesearch.
The Energy Department's National Renewable Energy Laboratory (NREL) has released an updated proposal that will establish an international quality standard for photovoltaic (PV) module manufacturing. The document is intended for immediate use by PV manufacturers when producing modules on an industrial scale so they can increase investor, utility, and consumer confidence in PV system performance.
"Our recent research on 50,000 systems found that, during the time period we studied, just 0.1% of all PV systems were affected by damaged or underperforming modules and less than ...
A recent randomized trial that looked at the feasibility of 2013 guidelines issued by the American College of Surgeons Trauma Quality Improvement Project for trauma resuscitation found that delivering universal donor plasma to massively hemorrhaging patients can be accomplished consistently and rapidly and without excessive wastage in high volume trauma centers. The plasma is given in addition to red blood cell transfusions to optimize treatment.
The 2013 guidelines recommend that universal donor products be immediately available on arrival of severely injured patients, ...
Researchers have unraveled the elusive process by which small, highly vascular clusters of sensory cells in the carotid arteries "taste the blood," as a 1926 essay put it--the initial step in regulating blood-oxygen levels.
In the April 21 issue of the journal Science Signaling, a University of Chicago-based research team describes the precise mechanism that cells in the carotid bodies use to detect oxygen levels in the blood as it flows toward the brain. The cells translate that taste test into signals, sent through the carotid sinus nerve, a branch of the glossopharyngeal ...
MADISON - Scientists today demonstrated the potential for softwoods to process more easily into pulp and paper if engineered to incorporate a key feature of hardwoods. The finding, published in this week's Proceedings of the National Academy of Sciences, could improve the economics of the pulp, paper and biofuels industries and reduce those industries' environmental impact.
"What we've shown is that it's possible to pair some of the most economically desirable traits of each wood type," says John Ralph, the Great Lakes Bioenergy Research Center's (GLBRC) plants leader ...
PHILADELPHIA -- A team of Mayo Clinic researchers has succeeded in identifying the source of cancer in patients' gastrointestinal tracts by analyzing DNA markers from tumors. The results open the possibility that doctors could one day be able to screen for cancer anywhere in the body with a noninvasive blood test or stool sample. Such tests, if they prove practical and feasible, could mean greater convenience for patients and saved lives through earlier diagnosis of cancer, especially rare and often lethal diseases such as pancreatic cancer or lung cancer.
The researchers' ...
BUFFALO, N.Y. -- A new study by two researchers in the University at Buffalo School of Social Work has shown that parents who chronically neglect their children contribute to the likelihood that they will develop aggressive and delinquent tendencies later in adolescence, and the one factor that links neglect with those behaviors appears to be poor social skills.
While child neglect can include many different aspects, the study examined two: failure to provide for a child's basic needs and a lack of adequate supervision.
Failure to provide, which includes not meeting ...
TORONTO, April 21, 2015--The vast majority of surgeons continue to recommend that women 40 years old or older with an average risk for breast cancer be screened annually for the disease, despite a 2009
U.S. Preventive Services Task Force (USPSTF) recommendation that such women be screened biennially beginning at 50 years old and continuing through age 74.
A team of researchers studying the efficacy of policy recommendations on practicing surgeons found that 88% of breast surgeons and 82% of general surgeons continue to recommend annual mammography for women with an ...
PHILADELPHIA - Liver cancer is often lethal in humans because it is diagnosed in late stages, but new work in animal models has identified a potential diagnostic biomarker of the disease and a potential way to reverse the damage done. The study will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2015 in Philadelphia.
Ying Fu, PhD, of Georgetown Lombardi Comprehensive Cancer Center explains this new work:
"Hepatocellular carcinoma, the most common form of liver cancer, remains the third leading cause of cancer-related deaths worldwide ...
The body's immune system may be the keeper of a healthy gut microbiota, report University of Chicago scientists on April 21 in the journal Immunity. They found that a single binding protein on white blood cells could affect whether or not mice produced a balanced gut microbiota. Without the protein, harmful bacteria were more easily able to cause infection. Why this happens is unclear, but it may be that the immune system has a way to sense the presence of invading intestinal bacteria.
"Our study reveals how our body's immune system shapes the gut microbiota to naturally ...
An immune cell protein, ID2, is critical for the maintenance of healthy gut microbiota and helps these good bacteria fight off harmful bacteria, report scientists from the University of Chicago. The study, published in Immunity on April 21, suggests that novel therapeutics or microbiota transplantation could be used to promote the development of good gut microbiota to indirectly kill harmful bacteria for patients with recurrent gut infection.
"Our study reveals how our body's immune system shapes the gut microbiota to naturally limit infections," says senior author Yang-Xin ...
